Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Normobaric Hyperoxygenation for Prevention of Contrast Induced Nephropathy.

NCT01448889 is registered in ClinicalTrials.gov with Assaf-Harofeh Medical Center as lead sponsor.

NCT NCT01448889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01448889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Normobaric Hyperoxygenation for Prevention of Contrast Induced Nephropathy.
Lead sponsor
Assaf-Harofeh Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2009
Completion date
December 31, 2012
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nephropathy